Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence.
Jeongmin LeeSue Hyun LeeHyunah KimSeung-Hwan LeeJae Hyoung ChoHyunyong LeeHyeon Woo YimKun-Ho YoonHun Sung KimJu Han KimPublished in: Journal of clinical pharmacy and therapeutics (2020)
The present study provides real-world evidence of the LDL-C reduction benefits associated with statin/ezetimibe combinations in the clinical practice setting. The results also demonstrate that if statin monotherapy does not effectively help patients reach their target LDL-C goals, changing to a statin/ezetimibe combination prescription may show enhanced LDL-C-lowering effects and improve the likelihood of achieving LDL-C targets, in real practice.